Stryker invests $400M in CMR Surgical, gets option on remaining equity
Overview
Stryker has invested about $400 million in CMR Surgical and holds an exclusive option to acquire the rest of its equity, according to The Robot Report.
Stryker also becomes the exclusive U.S. sales agent for CMR's Versius surgical robot portfolio, while CMR keeps commercializing Versius elsewhere.
The transaction is subject to regulatory approvals and customary closing conditions.
Written by AI from the articles below · updated Oct 15, 1:09 PM ET
Check the sources:
Article timeline
The articles in this story. Times are ET.
- The Robot ReportNewsStryker invests $400M in CMR Surgical with option to acquire it
AIStryker has invested about $400 million in CMR Surgical, with an exclusive option to acquire the rest of its equity. Stryker will also serve as the exclusive U.S. sales agent for the Versius surgical robot portfolio, while CMR continues to commercialize it elsewhere. The transaction is subject to regulatory approvals and customary closing conditions.
Heat trend
Not enough continuous observations to show a trend yet.